结直肠癌中去泛素化酶的作用机制

Colorectal cancer ranks among the malignancies with high incidence and mortality rates, posing significant challenges to its prevention and treatment. In recent years, accumulating evidence has highlighted the critical involvement of deubiquitinases in the development and progression of colorectal cancer. Deubiquitinases meticulously remove ubiquitin moieties from proteins, thereby regulating protein stability, cellular signaling cascades, and gene expression, which in turn impacts key processes in tumor cells such as proliferation, survival, and metastasis. Deubiquitinases can influence the stability of cell cycle proteins, promoting cell cycle progression and accelerating cellular proliferation. Within the Wnt/ β-catenin signaling pathway, deubiquitinases contribute to pathway hyperactivation by enhancing nuclear localization of β-catenin, a pivotal event in colorectal cancer initiation. Deubiquitinases also play a role in modulating the stability of immune checkpoint regulators, affecting the function of immune cells within the tumor microenvironment and facilitating immune evasion. Through regulation of transcription factor ubiquitination status, deubiquitinases impact target gene expression, promoting epithelial-mesenchymal transition, thereby augmenting colorectal cancer’s invasive and metastatic potential. Moreover, deubiquitinases mediate chemoresistance in tumor cells by controlling the stability of apoptosis inhibitors, DNA repair enzymes, or drug efflux pumps. Given the critical role of deubiquitinases in colorectal cancer progression, the development of small molecule inhibitors targeting specific deubiquitinases has emerged as an attractive yet challenging field of research. Several inhibitors have demonstrated the capability to inhibit colorectal cancer cell growth and induce apoptosis in vitro and animal models. This review delves into the advancements in understanding the roles of deubiquitinases in colorectal cancer and discusses the application of small molecule inhibitors in colorectal cancer, providing insights for therapeutic strategies against this disease.